Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 1
2014 1
2015 2
2016 1
2017 5
2018 5
2019 1
2020 2
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Anti-bacterial Monoclonal Antibodies.
Nagy E, Nagy G, Power CA, Badarau A, Szijártó V. Nagy E, et al. Among authors: szijarto v. Adv Exp Med Biol. 2017;1053:119-153. doi: 10.1007/978-3-319-72077-7_7. Adv Exp Med Biol. 2017. PMID: 29549638 Review.
Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients.
Klussmann JP, Grosheva M, Meiser P, Lehmann C, Nagy E, Szijártó V, Nagy G, Konrat R, Flegel M, Holzer F, Groß D, Steinmetz C, Scherer B, Gruell H, Schlotz M, Klein F, de Aragão PA, Morr H, Al Saleh H, Bilstein A, Russo B, Müller-Scholtz S, Acikel C, Sahin H, Werkhäuser N, Allekotte S, Mösges R. Klussmann JP, et al. Among authors: szijarto v. Sci Rep. 2023 Apr 26;13(1):6839. doi: 10.1038/s41598-023-32546-z. Sci Rep. 2023. PMID: 37100830 Free PMC article. Clinical Trial.
Directly Bactericidal Anti-Escherichia coli Antibody.
Szijártó V, Nagy E, Nagy G. Szijártó V, et al. Trends Microbiol. 2018 Aug;26(8):642-644. doi: 10.1016/j.tim.2018.05.016. Epub 2018 Jun 11. Trends Microbiol. 2018. PMID: 29903418
Antiviral Potential of Azelastine against Major Respiratory Viruses.
Fischhuber K, Bánki Z, Kimpel J, Kragl N, Rössler A, Bolze A, Muellauer B, Angerer J, Nagy G, Nagy E, Szijarto V. Fischhuber K, et al. Among authors: szijarto v. Viruses. 2023 Nov 23;15(12):2300. doi: 10.3390/v15122300. Viruses. 2023. PMID: 38140540 Free PMC article.
Cross-specificity of protective human antibodies against Klebsiella pneumoniae LPS O-antigen.
Rollenske T, Szijarto V, Lukasiewicz J, Guachalla LM, Stojkovic K, Hartl K, Stulik L, Kocher S, Lasitschka F, Al-Saeedi M, Schröder-Braunstein J, von Frankenberg M, Gaebelein G, Hoffmann P, Klein S, Heeg K, Nagy E, Nagy G, Wardemann H. Rollenske T, et al. Among authors: szijarto v. Nat Immunol. 2018 Jun;19(6):617-624. doi: 10.1038/s41590-018-0106-2. Epub 2018 May 14. Nat Immunol. 2018. PMID: 29760533
Evaluation of the Safety, Tolerability and Immunogenicity of ShigETEC, an Oral Live Attenuated Shigella-ETEC Vaccine in Placebo-Controlled Randomized Phase 1 Trial.
Girardi P, Harutyunyan S, Neuhauser I, Glaninger K, Korda O, Nagy G, Nagy E, Szijártó V, Pall D, Szarka K, Kardos G, Henics T, Malinoski FJ. Girardi P, et al. Among authors: szijarto v. Vaccines (Basel). 2022 Feb 21;10(2):340. doi: 10.3390/vaccines10020340. Vaccines (Basel). 2022. PMID: 35214798 Free PMC article.
The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue.
Konrat R, Papp H, Kimpel J, Rössler A, Szijártó V, Nagy G, Madai M, Zeghbib S, Kuczmog A, Lanszki Z, Gesell T, Helyes Z, Kemenesi G, Jakab F, Nagy E. Konrat R, et al. Among authors: szijarto v. Front Pharmacol. 2022 Jun 30;13:861295. doi: 10.3389/fphar.2022.861295. eCollection 2022. Front Pharmacol. 2022. PMID: 35846988 Free PMC article.
24 results